Titel

Merkliste
1 Ergebnisse

PRISMA 2020 checklist:

Bai-Ru Cheng (11685241) ; Jia-Qi Chen (3897487) ; Xiao-Wen Zhang (334871)...
https://figshare.com/articles/journal_contribution/PRISMA_2020_checklist_/17322851. , 2021

Link: https://doi.org/10.1371/journal.pone.0261239.s002

RT Journal
T1 <Title>PRISMA 2020 checklist</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_17322851&Exemplar=1&LAN=DE
				
A1 Bai-Ru Cheng (11685241)
A1 Jia-Qi Chen (3897487)
A1 Xiao-Wen Zhang (334871)
A1 Qin-Yang Gao (11864477)
A1 Wei-Hong Li (11864480)
A1 Li-Jiao Yan (11864483)
A1 Yu-Qiao Zhang (11864486)
A1 Chang-Jiang Wu (11864489)
A1 Jing-Li Xing (11864492)
A1 Jian-Ping Liu (257873)
YR 2021
K1 Medicine
K1 Pharmacology
K1 Biotechnology
K1 Immunology
K1 Developmental Biology
K1 Cancer
K1 Science Policy
K1 Infectious Diseases
K1 two authors independently
K1 remains uncertain whether
K1 80 – 1
K1 66 – 0
K1 57 – 0
K1 cardiovascular mortality rate
K1 oral celecoxib compared
K1 pooled risk ratio
K1 xlink "> celecoxib
K1 analysis </ p
K1 xlink ">
K1 celecoxib compared
K1 risk ratio
K1 cause mortality
K1 cardiovascular safety
K1 would remain
K1 systematic review
K1 study selection
K1 steroid anti
K1 significant difference
K1 selective nsaid
K1 rheumatoid arthritis
K1 relatively safe
K1 randomized trials
K1 july 22
K1 inflammatory drugs
K1 effect size
K1 data extraction
K1 confidence interval
K1 conducted searches
K1 cochrane central
K1 99 )
K1 98 )
K1 21 trials
K1 00 )
JF https://figshare.com/articles/journal_contribution/PRISMA_2020_checklist_/17322851
LK http://dx.doi.org/https://doi.org/10.1371/journal.pone.0261239.s002
DO https://doi.org/10.1371/journal.pone.0261239.s002
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)